Archit Organosys Limited has announced its financial results for the quarter and half-year ended September 30, 2025, showcasing robust growth in both revenue and profitability.

Financial Highlights

The company reported a significant increase in its net profit for the half-year period, rising to Rs 367.61 lakhs compared to Rs 202.46 lakhs in the previous year, marking an impressive growth of 81.7%. This substantial improvement in profitability underscores the company's effective cost management and operational efficiency.

Revenue from operations for the half-year also saw a notable uptick, reaching Rs 6,605.55 lakhs, up from Rs 5,214.97 lakhs in the prior year, representing a 26.7% increase. This growth in revenue indicates strong demand for the company's products and successful market penetration strategies.

For the quarter ended September 30, 2025, Archit Organosys posted a net profit of Rs 153.92 lakhs, a 51.5% increase from Rs 101.61 lakhs in the same quarter last year.

Key Financial Metrics

All financial figures in Rs lakhs, except for EPS

Operational Performance

The company's operating profit before working capital changes for the half-year stood at Rs 704.65 lakhs, indicating strong operational efficiency. The cash flow from operating activities remained positive at Rs 344.13 lakhs, reflecting healthy cash generation from core operations.

Balance Sheet Strength

As of September 30, 2025, Archit Organosys reported total assets of Rs 12,394.82 lakhs, with a strong equity base of Rs 7,278.09 lakhs. The company's financial position appears robust, with a balanced mix of equity and debt financing.

Management Commentary

The Board of Directors approved these unaudited financial results in their meeting held on November 13, 2025. While specific management comments were not provided in the available data, the significant improvement in financial performance suggests effective execution of the company's business strategies.

Segment Information

Archit Organosys operates in a single segment of Chemicals and Organics, aligning its focus on core competencies. The company does not have any subsidiary companies, simplifying its corporate structure and financial reporting.

Conclusion

Archit Organosys Limited's financial results for the first half of FY2026 demonstrate strong growth momentum, with substantial improvements in both top-line and bottom-line performance. The company's ability to significantly enhance profitability while expanding revenue indicates effective cost management and potentially improved market positioning in the chemicals and organics sector.

Investors and stakeholders may find these results encouraging, particularly the notable increase in net profit and earnings per share. However, it's important to consider these results in the context of broader market conditions and industry trends when making investment decisions.

As always, investors are advised to conduct their own research and consider their financial goals before making any investment choices.

Archit Organosys Limited, a chemicals and organics company, has reported a significant increase in its net profit for the quarter ended June 30. The company's Board of Directors approved the unaudited financial results and made key decisions in a meeting held on August 13.

Financial Performance

Archit Organosys saw its net profit more than double to Rs 203.59 crore in Q1, compared to Rs 100.54 crore in the same quarter of the previous year, marking a 103% year-on-year increase. The company's revenue from operations also showed strong growth, rising to Rs 3,319.56 crore from Rs 2,700.44 crore in the corresponding quarter, representing a 23% increase.

The company's financial results for Q1 are summarized in the table below:

The company's total income for the quarter stood at Rs 3,419.09 crore, up from Rs 2,747.03 crore in the same period last year. The profit before tax also saw a substantial increase, rising to Rs 304.76 crore from Rs 141.08 crore in the previous year's Q1.

Improved Profitability

Archit Organosys demonstrated improved profitability, with its basic earnings per share (EPS) rising to Rs 0.99 from Rs 0.49 in the corresponding quarter of the previous year. This 102% increase in EPS reflects the company's strong financial performance and increased shareholder value.

Appointment of New Secretarial Auditor

In addition to approving the financial results, the Board of Directors appointed M/s Ankit Sethi & Associates as the company's Secretarial Auditor. The appointment is for a term of five consecutive years, from April 1, 2025, to March 31, 2030, subject to shareholder approval at the upcoming Annual General Meeting.

M/s Ankit Sethi & Associates is a peer-reviewed practicing Company Secretaries firm with over 10 years of experience. The firm, led by Mr. Ankit Sethi, specializes in listed company compliances, secretarial audits, due diligence, mergers and acquisitions, and other strategic corporate restructurings.

Company Overview

Archit Organosys Limited operates in the chemicals and organics segment. The company's financial results are prepared in accordance with Indian Accounting Standards (Ind-AS) as prescribed under the Companies Act, 2013.

The strong financial performance of Archit Organosys in Q1 demonstrates the company's resilience and growth potential in the chemicals and organics sector. The appointment of an experienced secretarial auditor also reflects the company's commitment to maintaining high standards of corporate governance and compliance.